Edgewater Capital acquire biopharma services provider HTI

Edgewater Capital to acquire biopharma services provider HTI

9:51 AM, 14th October 2019
Edgewater Capital logo

ESSEX JUNCTION / CLEVELAND, US: Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated (HTI). Haematologic is a leading provider of biologic products and GMP compliant assay development and testing services to the biopharmaceutical industry.

Haematologic’s product line includes proteins, antibodies and associated reagents for thrombosis research and in-vitro diagnostic applications.

Founded in 1987 by Kenneth Mann, a prominent scientist in the field of thrombosis and hemostasis, HTI has established itself as the authority within the blood coagulation and protein chemistry fields, including deep expertise in the purification, characterization and testing of coagulation and plasma proteins.

The company has grown to become a leading provider of coagulation reagents and bioanalytical services through its focus in custom protein purification, protein modification, assay development, and GMP compliant stability and release testing. The Company’s services span early pre-clinical development through testing and release of commercial Biologics.

“HTI is extremely excited to partner with Edgewater as we enter our next phase of growth. We strive to continually serve our customers with our technical support, deep expertise in protein biochemistry, and strong focus on quality. This partnership will greatly enhance our ability to achieve our goals and will further enhance our ability to produce innovative solutions for our clients.  Together with Edgewater, we will focus on becoming a leading outsourced services partner to the biologics industry,” said Richard Jenny, President and Chief Executive Officer of Haematologic Technologies. 

“We are excited to have HTI join the Edgewater family and to support the next phase of the Company’s growth as they increasingly become a premier outsource partner for the biopharmaceutical industry. The business’ deep expertise and proven innovation in assay and method development for leading biopharmaceutical companies, coupled with a broad portfolio of products critical in blood diagnostics and biologic clinical trials, have positioned the Company as the leading authority in their area of focus.  We are eager to build on this platform and to partner with the talented technical team at Haematologic Technologies,” added Robert Girton, Partner, Edgewater Capital.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

HUUB, Devan Chemicals debut its Moov&Cool fabric in Kona

DERBY, UK/ RONSE, BELGIUM: Wetsuit and apparel specialist HUUB has collaborated with textile innovator Devan Chemicals to bring even more performance- ...

Read more
Total, Adani in $600 mn deal to supply and market natural gas in India

PARIS, FRANCE: Total SA expands its partnership with the Adani Group; the largest energy and infrastructure conglomerate in India, to contribute to th ...

Read more
ThyssenKrupp to provide consultancy services for Nayara Energy’s petchem units in India

MUMBAI, INDIA: ThyssenKrupp Industrial Solutions (India), has inked a contract with Nayara Energy, an integrated downstream company, through a gl ...

Read more
Indian firm develops fire-resistant paint

HYDERABAD, INDIA: At a time, when there is a growing concern around fire incidents in residential, commercial and industrial establishments causing lo ...

Read more
Bayer inks deals with eleven digital healthcare startups

BERLIN, GERMANY: Bayer has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these start ...

Read more
BASF advances scientific research in Asia Pacific through 2020 grant

SINGAPORE: BASF is calling upon the research and academic community in Asia Pacific to submit research proposals to the Nutrition Asia Research Grant ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X